NCT00234338View on ClinicalTrials.gov

Study Evaluating Prevenar in High-Risk Children

CompletedOBSERVATIONAL

Enrollment

5,000

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

April 30, 2007

Conditions

Pneumococcal Disease

Trial Locations (1)

60590

Frankfurt

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00234338 - Study Evaluating Prevenar in High-Risk Children | Biotech Hunter | Biotech Hunter